Trade Summary

3 days ago, Thomas John, serving as Dir at Genelux Corp (GNLX), sold 10,000 shares at $2.90 per share, for a total transaction value of $28,957.00. Following this transaction, Thomas John now holds 482,784 shares of GNLX.

This sale represents a 2.00% decrease in Thomas John's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 3, 2026, 1 day after the trade was made.

Genelux Corp operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.